Theracom, L.L.C.

Theracom, L.L.C., a Kentucky-based pharmaceutical distributor, supplies specialty biologic medications to federal healthcare systems as a prime contractor operating exclusively on full-and-open competitive purchase orders with no set-aside designations. Theracom is a child entity of Cencora, Inc. (doing business as AmerisourceBergen), one of the nation's largest pharmaceutical distribution companies, and operates from its facility in Brooks, Kentucky, with a registered SAM profile dating to 2006.

Theracom's federal work consists almost entirely of emergency and routine purchase orders for TAKHZYRO (lanadelumab and pegtanercept), a high-cost biologic therapy used to treat hereditary angioedema. Recent awards span firm fixed-price purchase orders from the Department of Veterans Affairs Veterans Integrated Service Networks (VISN 2, VISN 5, and VISN 6) and the Department of the Navy Bureau of Medicine and Surgery, with individual order ceilings typically between $37,700 and $75,500. Individual order completion cycles run two to thirty days, reflecting urgent pharmaceutical supply needs within federal healthcare systems. Performance occurs at Theracom's Brooks, Kentucky location or at requesting medical facilities (Northport VAMC, Northport New York).

Federal healthcare customers dominate the award portfolio. The top five customer agencies by potential value — the Department of the Army Medical Command ($1.1 million across ten awards), Veterans Integrated Service Network 6 ($637 thousand across forty-two awards), Veterans Integrated Service Network 2 ($429 thousand across eleven awards), the Indian Health Service ($410 thousand across twenty-one awards), and the Navy Bureau of Medicine and Surgery ($364 thousand across thirty-one awards) — account for 56% of combined potential value. By award count, VISN 6 leads with forty-two orders, followed by the Navy with thirty-one and the Indian Health Service with twenty-one. The source data reflects 437 prime awards since 2006, with 15 awards in 2026 year-to-date, generating $5.3 million in combined potential value and $4.2 million in obligated dollars. Activity clusters in pharmaceutical wholesaling (88 awards under NAICS 424210) and medical supplies distribution, with 202 awards coded to PSC Medical And Surgical Instruments and 177 to Drugs And Biologicals.

Theracom operates as a 100% prime contractor with no documented subcontract footprint. A single parent vehicle appears in the source — a Blanket Purchase Agreement (HHSI246201400158B) with the Health and Human Services Indian Health Service carrying five task orders worth $91 thousand. Most federal work flows through direct purchase orders rather than standing IDIQs or GWACs. One award faces recompete within the next twenty-four months (combined potential value $39 thousand). Parent company Cencora, Inc. maintains a substantial Defense Logistics Agency Troop Support Medical indefinite delivery contract valued up to $999.99 million through December 2031, positioning the organization as critical infrastructure in the federal pharmaceutical supply chain, though Theracom's own work does not extend to that vehicle.